Tofflon Science and Technology Group Co., Ltd. (SHE:300171)

Market Cap	12.72B +34.2%
Revenue (ttm)	5.22B +8.7%
Net Income	172.92M +2.0%
EPS	0.23 +4.7%
Shares Out	760.85M
PE Ratio	72.07
Forward PE	111.47
Dividend	0.06 (0.35%)
Ex-Dividend Date	Sep 25, 2025

Volume	8,210,311
Average Volume	10,340,680
Open	16.97
Previous Close	16.93
Day's Range	16.70 - 17.18
52-Week Range	10.60 - 20.37
Beta	0.32
RSI	56.13
Earnings Date	Apr 29, 2026

About SHE:300171

Tofflon Science and Technology Group Co., Ltd. engage in the research, development, production, sales, and services of pharmaceutical equipment in China and internationally. It operates through four segments: Biotechnology, Preparation Equipment, Engineering, and Food Engineering. The company offers technological research, such as cell technology, complex preparation, injection, and OSD laboratory; instruments, including cell therapy and nucleic acid drugs instruments, and table reactor; cryopreservation system for seeds and biological samples,...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1993
• Employees: 5,417
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300171

Financial Performance

In 2024, SHE:300171's revenue was 5.01 billion, a decrease of -11.19% compared to the previous year's 5.64 billion. Earnings were 194.09 million, a decrease of -67.66%.